Search Results - "Getz, Jennifer A"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases by Erster, Oran, Thomas, Jerry M., Hamzah, Juliana, Jabaiah, Abeer M., Getz, Jennifer A., Schoep, Tobias D., Hall, Sejal S., Ruoslahti, Erkki, Daugherty, Patrick S.

    Published in Journal of controlled release (10-08-2012)
    “…As a general strategy to selectively target antibody activity in vivo, a molecular architecture was designed to render binding activity dependent upon…”
    Get full text
    Journal Article
  3. 3

    A novel quantitative kinase assay using bacterial surface display and flow cytometry by Henriques, Sónia Troeira, Thorstholm, Louise, Huang, Yen-Hua, Getz, Jennifer A, Daugherty, Patrick S, Craik, David J

    Published in PloS one (15-11-2013)
    “…The inhibition of tyrosine kinases is a successful approach for the treatment of cancers and the discovery of kinase inhibitor drugs is the focus of numerous…”
    Get full text
    Journal Article
  4. 4

    A novel biomarker assay qualification strategy for rare human matrices - a case study of biomarkers in aqueous humor by Getz, Jennifer A, Nguy, Trung, Dere, Randall, Maia, Mauricio

    Published in Bioanalysis (2024)
    “…Measuring pharmacodynamic biomarkers near the therapeutic site of action presents considerable challenges for sites with limited matrix volume or difficult…”
    Get more information
    Journal Article
  5. 5

    Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal Antibodies by Adedeji, Adeyemi O., Zhong, Fiona, Getz, Jennifer A., Zhong, Zoe, Halpern, Wendy

    Published in Toxicologic pathology (01-12-2022)
    “…Removal of the core fucose from the Fc region of humanized monoclonal antibodies (afucosylated antibodies) enhances their antibody-dependent cell cytotoxicity…”
    Get full text
    Journal Article
  6. 6

    Design of a Cyclotide Antagonist of Neuropilin‑1 and -2 That Potently Inhibits Endothelial Cell Migration by Getz, Jennifer A, Cheneval, Olivier, Craik, David J, Daugherty, Patrick S

    Published in ACS chemical biology (21-06-2013)
    “…Neuropilin-1 and -2 are critical regulators of angiogenesis, lymphangiogenesis, and cell survival as receptors for multiple growth factors. Disulfide-rich…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Protease-Resistant Peptide Ligands from a Knottin Scaffold Library by Getz, Jennifer A, Rice, Jeffrey J, Daugherty, Patrick S

    Published in ACS chemical biology (19-08-2011)
    “…Peptides within the knottin family have been shown to possess inherent stability, making them attractive scaffolds for the development of therapeutic and…”
    Get full text
    Journal Article
  9. 9

    Peptide discovery using bacterial display and flow cytometry by Getz, Jennifer A, Schoep, Tobias D, Daugherty, Patrick S

    Published in Methods in enzymology (2012)
    “…Peptides are increasingly used as therapeutic and diagnostic agents. The combination of bacterial cell-surface display peptide libraries with magnetic- and…”
    Get more information
    Journal Article
  10. 10

    Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics by Jabaiah, Abeer M, Getz, Jennifer A, Witkowski, Witold A, Hardy, Jeanne A, Daugherty, Patrick S

    Published in Biological chemistry (01-09-2012)
    “…Many peptidases are thought to require non-active site interaction surfaces, or exosites, to recognize and cleave physiological substrates with high…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry: e80474 by Henriques, Sonia Troeira, Thorstholm, Louise, Huang, Yen-Hua, Getz, Jennifer A, Daugherty, Patrick S, Craik, David J

    Published in PloS one (01-11-2013)
    “…The inhibition of tyrosine kinases is a successful approach for the treatment of cancers and the discovery of kinase inhibitor drugs is the focus of numerous…”
    Get full text
    Journal Article
  14. 14

    High-Affinity, Stable Peptide Ligands Engineered from a Kalata B1 Knottin Library by Getz, Jennifer A

    Published 01-01-2012
    “…The widespread adoption of peptide therapeutics has been restricted by their poor stability and therefore their limited in vivo half-life and oral…”
    Get full text
    Dissertation